Medium-term Environmental Plan
To effectively practice environmental management, ASKA Pharmaceutical, the core subsidary of the Group, formulated the Medium-term Environmental Plan and regularly holds the Company-wide Environmental Management Meeting. Discussion at FY2023 meeting covered the FY2022 results under the medium-term environmental plan and the goals for FY2023.
We believe that information sharing and exchange of opinions among the attendees help to promote environmental measures throughout the Company..
Environmental Management System
Environmental Audit
ASKA Pharmaceutical Iwaki Factory, which is responsible for the production functions of our group, has obtained ISO 14001 certification, an international standard for environmental management systems. We maintain and renew our certification by undergoing regular external audits. In addition to external audits, we also conduct regular internal audits to ensure that our environmental management system is being properly implemented.
Acquisition status of ISO 14001 certification
|
FY2019 |
FY2020 |
FY2021 |
FY2022 |
FY2023 |
ISO14001
Number of certified facilities |
1 |
1 |
1 |
1 |
1 |
ISO14001
Certification rate (%) |
100 |
100 |
100 |
100 |
100 |
Support for our business partners' environmental initiatives
The Group strives to take into account the environment, including climate change, in all its business activities. We aim to contribute to the conservation of the global environment and the realization of a sustainable society, and we seek to ensure that our business partners understand our environmental management and environmental philosophy.
We also support our business partners' environmental initiatives through green procurement.
- For details, please see the page “Supply Chain”.
Supply Chain